E-ISSN: 2536-507X ISSN: 2149-7893
Potential Predictive Factors for Breast Cancer Subtypes from a North Cyprus Cohort Analysis
PDF
Cite
Share
Request
Original Article
VOLUME: 5 ISSUE: 4
P: 339-349
December 2020

Potential Predictive Factors for Breast Cancer Subtypes from a North Cyprus Cohort Analysis

Cyprus J Med Sci 2020;5(4):339-349
DOI: 10.5152/cjms.2020.2291
Ayse Ulgen 1,2
Özlem Gürkut 3
Wentian Li 4
1. Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, USA
2. Girne American University, School of Medicine, Kyrenia, Cyprus
3. Department of Oncology, Dr Burhan Nalbantoğlu State Hospital, Nicosia, Cyprus
4. The Robert S. Boas Center for Genomics and Human Genetics, The Feinstein Institutes for Medical Research, Northwell Health, NY, USA
No information available.
No information available
Received Date: 12.06.2020
Accepted Date: 28.11.2020
PDF
Cite
Share
Request

ABSTRACT

BACKGROUND/AIMS

We present the first epidemiological survey from North Cyprus to determine the predictive factors for breast cancer subtypes.

MATERIAL and METHODS

More than 300 patients with breast cancer, with 90% of them having the cancer subtype information, were examined at the State Hospital in Nicosia between 2006 and 2015 for their demographic, reproductive, genetic, and epidemiological factors. The breast cancer subtypes and the estrogen receptor (ER) +/- progesterone receptor (PR) +/- and human epidermal growth factor 2 (HER2) +/- status were determined. Single and multiple variable regularized regressions, with predictive factors as independent variables and breast cancer subtypes as dependent variables, were conducted.

RESULTS

Our cohort differed significantly from larger cohorts (e.g., the Breast Cancer Family Registry) in terms of age, menopause status, age at menarche, parity, education, oral contraceptive use, and breastfeeding, but the distribution of breast cancer subtypes was not significantly different. The subtype distribution in our cohort was also not different from that of another Turkish cohort. We found that the ER+ subtype was positively related to age/postmenopause, ER+/PR+ subtype was associated positively with age but negatively with cancer stage, and HER2+ subtype that negatively correlated with ER+ and ER+/PR+ was associated positively with cancer stage but negatively with age/postmenopause.

CONCLUSION

Assuming ER+ and ER+/PR+ to have better prognostic, HER+ to have worse prognostic, then older age and postmenopause seem to be beneficial, smoking and family history of cancer seem to be detrimental. Further steps include exploring potential biomarkers and using cure models to determine long-term breast cancer survivors.